By JOHN KANELIS / firstname.lastname@example.org
Is it just me or are we awash in COVID-19 vaccines these days?
Johnson & Johnson has just received approval to distribute its one-shot vaccine. It vows to deliver tens of millions of doses in a major hurry. The J&J medicine now joins Pfizer and Moderna; AstraZeneca is likely to win approval in short order, too.
A part of this ongoing drama needs some attention. It is the amazing development of the vaccines by these “big pharma” outfits.
Think of it. The world became affected a bit more than a year ago by the coronavirus. There might have some research being done at that time, but then Donald John Trump declared — finally! — a national emergency. He sought to get the drug companies fired up to produce the vaccine. Then he bungled the start-up, along with damn near everything else regarding our national response to the pandemic.
Still, the pharmaceutical firms kept at it. There have been some arguments over whether the federal government funding of the research had a tangible impact on the companies’ ability to deliver the vaccines.
They did. Pfizer came out first. Moderna followed shortly after. Now we have J&J.
As a point of personal privilege, my wife and I have been vaccinated fully with the Pfizer drug; one of our sons has received his vaccine from Moderna. We are praying that our entire family — extended and immediate — gets inoculated against this disease.
I want to salute the researchers at these big pharma companies for delivering the vaccines that now are beginning to reel in the impact of the virus.
Why, I’ll even offer a good word for Donald Trump, who promised a quick delivery of the vaccine. It happened pretty much as the ex-president said it would.